Last updated: 2026-09-07 07:20:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Zimmer Biomet Holdings, Inc. (ZBH) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $98.05, with a market capitalization of $18.71B and a P/E ratio of 23.19. Over the past 52 weeks, its price has ranged from $79.12 to $106.88. This page covers its latest market performance, valuation, price trends and company information.
$18.71B | |
$97.77 | |
$180.36 | |
$74.37 | |
$98.92 | |
1.00M | |
2.19M | |
23.19 | |
$106.88 | |
$79.12 | |
1.01% | |
-- |
Zimmer Biomet Holdings, Inc. (ZBH) last closed at $98.92 as of 2026-09-05 00:01:00, unchanged from the previous close of $98.92.
During the latest regular trading session, ZBH traded between $74.37 and $180.36, with a volume of 1.00M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Zimmer Biomet Holdings, Inc. (ZBH) moved from $99.48 to $98.05, representing a decline of 1.44% ($1.43).
The stock traded between $96.84 and $102.86 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 1.32 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 68.2%
ZBH is currently trading at $98.05, placing it 68.2% of the way from its 52-week low of $79.12 to its 52-week high of $106.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 17000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Zimmer Biomet Holdings, Inc. (ZBH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.